The structure-function relationship of oncogenic LMTK3
Ditsiou A., Cilibrasi C., Simigdala N., Papakyriakou A., Milton-Harris L., Vella V., Nettleship JE., Lo JH., Soni S., Smbatyan G., Ntavelou P., Gagliano T., Iachini MC., Khurshid S., Simon T., Zhou L., Hassell-Hart S., Carter P., Pearl LH., Owen RL., Owens RJ., Roe SM., Chayen NE., Lenz H-J., Spencer J., Prodromou C., Klinakis A., Stebbing J., Giamas G.
The structure of oncogenic LMTK3 determines its role and functions allowing drug inhibition as a new therapeutic strategy.